Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pneumococcal vaccine
Pharma
Merck's pneumococcal shot Capvaxive off to 'very strong start'
In Q3, Merck recorded encouraging sales for Capvaxive, which is the world's first pneumococcal vaccine designed specifically for adults.
Kevin Dunleavy
Oct 30, 2025 11:12am
SK defeats Pfizer in Korean patent feud
May 21, 2025 9:39am
Pfizer enlists Elizabeth Banks for pneumococcal vaccine push
Mar 19, 2025 3:20pm
Argentina biotech to produce Pfizer's Prevnar 20 in access push
Jan 16, 2025 8:38am
CDC panel endorses broader pneumococcal vaccine use
Oct 23, 2024 5:40pm
Merck's new Capvaxive scores key CDC vaccine panel endorsement
Jun 28, 2024 11:44am
